R. Palmer

发表

WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin

Angeliki Kotsianti, Daniel A. Haber, W. Gerald, 2001, Current Biology.

The influence of a polymorphism in the gene encoding angiotensin converting enzyme (ACE) on treatment outcomes in late-onset Pompe patients receiving alglucosidase alfa

Xiwen Ma, R. Pomponio, A. McVie-Wylie, 2016, Molecular genetics and metabolism reports.

Broad spectrum of Pompe disease in patients with the same c.-32-13T→G haplotype

M. Ausems, M. Kroos, A. T. van der Ploeg, 2007, Neurology.

Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis.

W. Gerald, D. Haber, J. Oliner, 2002, Cancer cell.

Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations

S. Marie, P. Gutierrez, R. Mattaliano, 2009, Journal of Neurology.

Transcriptional Activation of Placental Growth Factor by the Forkhead/Winged Helix Transcription Factor FoxD1

W. Gerald, R. Jensen, L. Hsiao, 2003, Current Biology.

Transcriptional response to GAA deficiency (Pompe disease) in infantile-onset patients.

K. Klinger, S. Marie, S. Madden, 2012, Molecular genetics and metabolism.

New Roles for the Snp1 and Exo84 Proteins in Yeast Pre-mRNA Splicing*

C. Mobarak, S. Ruby, R. Palmer, 2001, The Journal of Biological Chemistry.

Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein.

W. Gerald, D. Sgroi, D. Haber, 2003, Genes & development.

The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin

W. Gerald, D. Haber, J. Oliner, 1999, Cell.

SUMO modification is required for in vivo Hox gene regulation by the Caenorhabditis elegans Polycomb group protein SOP-2

D. Haber, S. Heuvel, A. Christoforou, 2004, Nature Genetics.

Rbm19 is a nucleolar protein expressed in crypt/progenitor cells of the intestinal epithelium.

D. Haber, A. Goldstein, Benedetta B Bonacci, 2005, Gene expression patterns : GEP.

Cascades of transcriptional induction during human lymphocyte activation.

P. Tamayo, D. Haber, R. Maki, 2001, European journal of cell biology.

Pompe disease (glycogen storage disease type II) in Argentineans: Clinical manifestations and identification of 9 novel mutations

N. Chamoles, R. Pomponio, M. Blanco, 2007, Neuromuscular Disorders.

A Functional Interaction with CBP Contributes to Transcriptional Activation by the Wilms Tumor Suppressor WT1*

D. Haber, L. Ellisen, R. Palmer, 2001, The Journal of Biological Chemistry.